Tamarack Capital Management, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
-21,693
(-5.1%)
New positions
1
Sold out positions
6
Turnover %
20.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ENDOLOGIX INC /DE/ | 18,340 | NEW |
| INSYS THERAPEUTICS INC | 10,671 | 117.3% |
| CARFUSION CORP | 9,837 | 53.7% |
| CATAMARAN CORP | 9,801 | 206.5% |
| VOLCANO CORP | 6,749 | 26.3% |
| NXSTAGE MEDICAL INC | 6,468 | 73.3% |
| CNMD | 5,948 | 248.5% |
| BIOMED REALTY TRUST COM | 3,116 | 38.2% |
| SURGALIGN HOLDINGS, INC. | 2,048 | 33.5% |
| DISCOVERY LABORATORIES INC N | 1,596 | 288.1% |
Top Reduces (Value $000, Stocks/ETFs)
| VARIAN MEDICAL SYSTEMS INC | -12,819 | -100.0% |
| DXCM | -10,977 | -100.0% |
| HEALTH CARE REIT INC COM | -8,839 | -100.0% |
| ATRC | -7,778 | -49.5% |
| ALKERMES PLC | -7,112 | -25.4% |
| PCRX | -4,312 | -100.0% |
| OPCH | -3,700 | -100.0% |
| SPECTRANETICS CORP COM | -3,345 | -17.4% |
| Oxford Immunotec Global PLC | -1,966 | -36.9% |
| *GREATBATCH INC | -1,624 | -9.2% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
105,912
(26.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|